Fentanyl dealers face felony charges for any 'substantial' role in overdose deaths
S. 5622 — Prosecuting Poison Pill Dealers Act · Filed by Ashley Moody (R-FL) · Introduced Sep 30, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends the Controlled Substances Act to establish criminal liability for drug dealers when their controlled substance is a 'substantial factor' in causing someone's death or serious bodily injury. The standard applies even when multiple substances contribute to the harm. Dealers and manufacturers of controlled substances face potential criminal charges if their product substantially contributes to a fatal or serious injury outcome.
Why we flagged it
The bill's operative mechanism is to broaden criminal liability under the Controlled Substances Act by defining when a controlled substance 'results in' death or injury. It does not create a new crime but expands the factual predicate for existing drug-trafficking offenses.
What the text implies
- The 'substantial factor' standard may capture situations where a dealer's substance was one of many contributing causes (e.g., fentanyl mixed with alcohol, or multiple drugs used together), potentially exposing dealers to felony charges even when causation is ambiguous or shared.
- No explicit requirement that the dealer knew or should have known the substance would be mixed with others or used in a manner causing death/injury; liability may attach based on foreseeability alone.
- The definition does not distinguish between intentional distribution to a known user and inadvertent supply; a dealer selling to someone who later combines the substance with others could face the same criminal exposure.
- Prosecutorial discretion in applying 'substantial factor' may vary widely across jurisdictions, creating uneven enforcement and potential for overreach in high-profile overdose cases.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill may deter drug trafficking and hold suppliers accountable for harms caused by their products, potentially protecting public health. However, the 'substantial factor' standard is broad and could criminalize conduct where a dealer's substance played only one of multiple contributing causes, raising concerns about proportionality and whether it adequately distinguishes between intentional distribution and negligent or accidental involvement.
Named in the bill
Controlled Substances Act, Section 102 (CSA), Drug dealers, Drug manufacturers, U.S. Department of Justice
Where it stands
- Sep 30, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- Sep 30, 2026 — Referred to Senate Committee on the Judiciary · Congress.gov: “Read twice and referred to the Committee on the Judiciary”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (704 characters) on Oct 16, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Fentanyl dealers face felony charges for any 'substantial' role in overdose deaths” QuorumCivic. https://share.quorumcivic.app/bill/119/s5622 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.